Projections of Ebola outbreak size and duration with and without vaccine use in Équateur, Democratic Republic of Congo, as of May 27, 2018.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 07 09 2018
accepted: 16 02 2019
entrez: 8 3 2019
pubmed: 8 3 2019
medline: 4 12 2019
Statut: epublish

Résumé

As of May 27, 2018, 6 suspected, 13 probable and 35 confirmed cases of Ebola virus disease (EVD) had been reported in Équateur Province, Democratic Republic of Congo. We used reported case counts and time series from prior outbreaks to estimate the total outbreak size and duration with and without vaccine use. We modeled Ebola virus transmission using a stochastic branching process model that included reproduction numbers from past Ebola outbreaks and a particle filtering method to generate a probabilistic projection of the outbreak size and duration conditioned on its reported trajectory to date; modeled using high (62%), low (44%), and zero (0%) estimates of vaccination coverage (after deployment). Additionally, we used the time series for 18 prior Ebola outbreaks from 1976 to 2016 to parameterize the Thiel-Sen regression model predicting the outbreak size from the number of observed cases from April 4 to May 27. We used these techniques on probable and confirmed case counts with and without inclusion of suspected cases. Probabilistic projections were scored against the actual outbreak size of 54 EVD cases, using a log-likelihood score. With the stochastic model, using high, low, and zero estimates of vaccination coverage, the median outbreak sizes for probable and confirmed cases were 82 cases (95% prediction interval [PI]: 55, 156), 104 cases (95% PI: 58, 271), and 213 cases (95% PI: 64, 1450), respectively. With the Thiel-Sen regression model, the median outbreak size was estimated to be 65.0 probable and confirmed cases (95% PI: 48.8, 119.7). Among our three mathematical models, the stochastic model with suspected cases and high vaccine coverage predicted total outbreak sizes closest to the true outcome. Relatively simple mathematical models updated in real time may inform outbreak response teams with projections of total outbreak size and duration.

Identifiants

pubmed: 30845236
doi: 10.1371/journal.pone.0213190
pii: PONE-D-18-26261
pmc: PMC6405095
doi:

Banques de données

figshare
['10.6084/m9.figshare.7598873.v1']

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0213190

Subventions

Organisme : NIGMS NIH HHS
ID : U01 GM087728
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Epidemics. 2013 Sep;5(3):131-45
pubmed: 24021520
Lancet Infect Dis. 2014 Dec;14(12):1189-95
pubmed: 25455986
PLoS Negl Trop Dis. 2016 Jul 19;10(7):e0004867
pubmed: 27434164
Science. 2013 Nov 15;342(6160):850-3
pubmed: 24233722
Bull World Health Organ. 1983;61(6):997-1003
pubmed: 6370486
Epidemics. 2014 Dec;9:70-8
pubmed: 25480136
J Infect Dis. 2018 Mar 28;217(8):1214-1221
pubmed: 29325149
Lancet. 2014 Oct 25;384(9953):1499-500
pubmed: 25390569
Trans R Soc Trop Med Hyg. 2011 Aug;105(8):466-72
pubmed: 21605882
Bull Soc Pathol Exot. 2005 Sep;98(3):218-23
pubmed: 16267964
Nature. 2014 Nov 6;515(7525):18
pubmed: 25373654
Lancet Infect Dis. 2015 Feb;15(2):147-8
pubmed: 25467648
Wkly Epidemiol Rec. 2003 Jun 27;78(26):223-8
pubmed: 15571171
Elife. 2015 Nov 03;4:
pubmed: 26525597
Am J Trop Med Hyg. 2018 May;98(5):1484-1488
pubmed: 29557329
Am J Epidemiol. 2004 Sep 15;160(6):509-16
pubmed: 15353409
Lancet. 2017 Feb 4;389(10068):505-518
pubmed: 28017403
J Infect Dis. 1999 Feb;179 Suppl 1:S65-75
pubmed: 9988167
MMWR Suppl. 2014 Sep 26;63(3):1-14
pubmed: 25254986
N Engl J Med. 2016 Aug 11;375(6):587-96
pubmed: 27509108
N Engl J Med. 2014 Nov 27;371(22):2054-7
pubmed: 25372854
Nature. 2005 Nov 17;438(7066):355-9
pubmed: 16292310
Epidemiol Infect. 2017 Apr;145(6):1069-1094
pubmed: 28166851
Lancet Glob Health. 2017 Mar;5(3):e254-e256
pubmed: 28193386
PLoS Negl Trop Dis. 2018 Jan 22;12(1):e0006161
pubmed: 29357363
Soc Sci Med. 2017 Dec;195:77-82
pubmed: 29156248
Emerg Infect Dis. 2018 Feb;24(2):336-344
pubmed: 29350151
Epidemics. 2015 Jun;11:80-4
pubmed: 25979285
PLoS Negl Trop Dis. 2016 Nov 15;10(11):e0005087
pubmed: 27846221
Bull World Health Organ. 1978;56(2):247-70
pubmed: 307455
Virulence. 2016;7(2):163-73
pubmed: 26399855
Philos Trans R Soc Lond B Biol Sci. 2017 May 26;372(1721):
pubmed: 28396473
J Infect Dis. 1999 Feb;179 Suppl 1:S76-86
pubmed: 9988168
Phys Life Rev. 2016 Sep;18:66-97
pubmed: 27451336
Health Hum Rights. 2016 Jun;18(1):115-128
pubmed: 27781004
J Health Commun. 2017;22(sup1):5-9
pubmed: 28854136
N Engl J Med. 2014 Oct 16;371(16):1481-95
pubmed: 25244186
N Engl J Med. 2014 Nov 27;371(22):2083-91
pubmed: 25317743
BMC Med. 2014 Oct 10;12:196
pubmed: 25300956
J Infect Dis. 2011 Nov;204 Suppl 3:S761-7
pubmed: 21987748
Lancet. 2018 Jun 9;391(10137):2321
pubmed: 29807665

Auteurs

J Daniel Kelly (JD)

School of Medicine, University of California, San Francisco (UCSF), San Francisco, CA, United States of America.
F.I. Proctor Foundation, UCSF, San Francisco, CA, United States of America.

Lee Worden (L)

School of Medicine, University of California, San Francisco (UCSF), San Francisco, CA, United States of America.
F.I. Proctor Foundation, UCSF, San Francisco, CA, United States of America.

S Rae Wannier (SR)

School of Medicine, University of California, San Francisco (UCSF), San Francisco, CA, United States of America.
F.I. Proctor Foundation, UCSF, San Francisco, CA, United States of America.

Nicole A Hoff (NA)

School of Public Health, University of California, Los Angeles, Los Angeles, CA, United States of America.

Patrick Mukadi (P)

National Institute of Biomedical Research, Kinshasa, Democratic Republic of Congo.

Cyrus Sinai (C)

School of Public Health, University of California, Los Angeles, Los Angeles, CA, United States of America.

Sarah Ackley (S)

School of Medicine, University of California, San Francisco (UCSF), San Francisco, CA, United States of America.
F.I. Proctor Foundation, UCSF, San Francisco, CA, United States of America.

Xianyun Chen (X)

Mathematics and Science College, Shanghai Normal University, Shanghai, China.

Daozhou Gao (D)

Mathematics and Science College, Shanghai Normal University, Shanghai, China.

Bernice Selo (B)

Ministry of Health, Kinshasa, Democratic Republic of Congo.

Mathais Mossoko (M)

Ministry of Health, Kinshasa, Democratic Republic of Congo.

Emile Okitolonda-Wemakoy (E)

School of Public Health, University of Kinshasa, Kinshasa, Democratic Republic of Congo.

Eugene T Richardson (ET)

Harvard Medical School, Boston, MA, United States of America.
Brigham and Women's Hospital, Boston, MA, United States of America.

George W Rutherford (GW)

School of Medicine, University of California, San Francisco (UCSF), San Francisco, CA, United States of America.

Thomas M Lietman (TM)

School of Medicine, University of California, San Francisco (UCSF), San Francisco, CA, United States of America.
F.I. Proctor Foundation, UCSF, San Francisco, CA, United States of America.

Jean Jacques Muyembe-Tamfum (JJ)

National Institute of Biomedical Research, Kinshasa, Democratic Republic of Congo.

Anne W Rimoin (AW)

School of Public Health, University of California, Los Angeles, Los Angeles, CA, United States of America.

Travis C Porco (TC)

School of Medicine, University of California, San Francisco (UCSF), San Francisco, CA, United States of America.
F.I. Proctor Foundation, UCSF, San Francisco, CA, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH